Inhalable Drug Delivery Devices Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Inhalable Drug Delivery Devices Market to 2025 - Global Analysis and Forecasts By Product (Pressurised Metered-dose Inhalers, Nebulisers, Dry Powder Inhalers, Thermal Vaporization Aerosol Devices, Others), End User (Hospitals and Clinics, Ambulatory Care Centre, Home Care, and Others) and Geography

Report Code: TIPMD00002336 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
An Inhalable drug delivery device is a medical device used for delivering medication into the body via the lungs. It is mainly used in the treatment of asthma and chronic obstructive pulmonary disease. Zanamivir, used to treat influenza, must be administered via inhaler. To reduce deposition in the mouth and throat, and to reduce the need for precise synchronization of the start of inhalation with actuation of the device, Inhalable drug delivery devices are sometimes used with a complementary spacer or holding chamber device.

The market of inhalable drug delivery devices is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing prevalence and incidence asthmatic cases, chronic and acute diseases in the global population can leads to major inhalation problem. Various technological developments such as nebulizers, dry powder inhalers, pressurized metered-dose inhalers in the healthcare industry in Asia Pacific and Europe are expected to offer growth opportunities for the players operating in the market.

The "Global Inhalable Drug Delivery Devices Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global inhalable drug delivery devices market trend. The report aims to provide an overview of global inhalable drug delivery devices with detailed market segmentation by product, end user and geography. The global inhalable drug delivery devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the inhalable drug delivery devices market.

The global inhalable drug delivery devices market is segmented on the basis of product, end user, and geography. The product segment in the inhalable drug delivery devices market includes, pressurized metered-dose inhalers, nebulizers, dry powder inhalers, thermal vaporization aerosol devices, others. Based on end user, the inhalable drug delivery devices market is segmented as, hospitals and clinics, ambulatory care center, home care, others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global inhalable drug delivery devices market based on product, end user, and geography. It also provides market size and forecast till 2025 for overall inhalable drug delivery devices market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the inhalable drug delivery devices market in the coming years, owing to factors such as, improved healthcare infrastructure and rising number of cardiovascular disorders in United States and Canada. Asia Pacific is expected to witness significant growth rate during the forecast period primarily due to the growth of healthcare industry in Asian countries such as, India, China and Japan in the inhalable drug delivery devices market.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key inhalable drug delivery devices market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are, Bespak, Propeller Health, Boehringer Ingelheim International GmbH, OMRON Corporation, GlaxoSmithKline plc, AstraZeneca, Sunovion Pharmaceuticals Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd, and Monaghan Medical Corporation.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. INHALABLE DRUG DELIVERY DEVICES MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Inhalable Drug Delivery Devices Market - By Product
3.2.2. Inhalable Drug Delivery Devices Market - By End User
3.2.3. Inhalable Drug Delivery Devices Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. INHALABLE DRUG DELIVERY DEVICES MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
?
5. INHALABLE DRUG DELIVERY DEVICES MARKET - GLOBAL ANALYSIS
5.1. GLOBAL INHALABLE DRUG DELIVERY DEVICES MARKET OVERVIEW
5.2. GLOBAL INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS
6. INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2025 - BY PRODUCT
6.1. OVERVIEW
6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. PRESSURISED METERED-DOSE INHALERS MARKET
6.3.1. Overview
6.3.2. Pressurised Metered-Dose Inhalers Market Revenue Forecasts and Analysis (US$ Mn)
6.4. NEBULISERS MARKET
6.4.1. Overview
6.4.2. Nebulisers Market Revenue Forecasts and Analysis (US$ Mn)
6.5. DRY POWDER INHALERS MARKET
6.5.1. Overview
6.5.2. Dry Powder Inhalers Market Revenue Forecasts and Analysis (US$ Mn)
6.6. THERMAL VAPORIZATION AEROSOL DEVICES MARKET
6.6.1. Overview
6.6.2. Thermal Vaporization Aerosol Devices Market Revenue Forecasts and Analysis (US$ Mn)
6.7. OTHERS MARKET
6.7.1. Overview
6.7.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

?
7. INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2025 - BY END USER
7.1. OVERVIEW
7.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. HOSPITALS AND CLINICS MARKET
7.3.1. Overview
7.3.2. Hospitals and Clinics Market Revenue Forecasts and Analysis (US$ Mn)
7.4. AMBULATORY CARE CENTRE MARKET
7.4.1. Overview
7.4.2. Ambulatory Care Centre Market Revenue Forecasts and Analysis (US$ Mn)
7.5. HOME CARE MARKET
7.5.1. Overview
7.5.2. Home Care Market Revenue Forecasts and Analysis (US$ Mn)
8. NORTH AMERICA INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
8.1. NORTH AMERICA INHALABLE DRUG DELIVERY DEVICES MARKET OVERVIEW
8.2. NORTH AMERICA INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
8.4. NORTH AMERICA INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
8.5. NORTH AMERICA INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
8.6. US MARKET OVERVIEW
8.6.1. US Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.6.2. US Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.7. CANADA MARKET OVERVIEW
8.7.1. Canada Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.7.2. Canada Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
?
8.8. MEXICO MARKET OVERVIEW
8.8.1. Mexico Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.8.2. Mexico Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9. EUROPE INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
9.1. EUROPE INHALABLE DRUG DELIVERY DEVICES MARKET OVERVIEW
9.2. EUROPE INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
9.4. EUROPE INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.5. EUROPE INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.6. UK MARKET OVERVIEW
9.6.1. UK Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.6.2. UK Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By End user (US$ Mn)
9.7. GERMANY MARKET OVERVIEW
9.7.1. Germany Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.7.2. Germany Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By End user (US$ Mn)
9.8. FRANCE MARKET OVERVIEW
9.8.1. France Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.8.2. France Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By End user (US$ Mn)
10. ASIA PACIFIC INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
10.1. ASIA PACIFIC INHALABLE DRUG DELIVERY DEVICES MARKET OVERVIEW
10.2. ASIA PACIFIC INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
10.4. ASIA PACIFIC INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.5. ASIA PACIFIC INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
10.6. JAPAN MARKET OVERVIEW
10.6.1. Japan Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.6.2. Japan Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By End user (US$ Mn)
10.7. CHINA MARKET OVERVIEW
10.7.1. China Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.7.2. China Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By End user (US$ Mn)
10.8. INDIA MARKET OVERVIEW
10.8.1. India Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.2. India Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By End user (US$ Mn)
11. MIDDLE EAST AND AFRICA (MEA) INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA INHALABLE DRUG DELIVERY DEVICES MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.4. MIDDLE EAST AND AFRICA INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. MIDDLE EAST AND AFRICA INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. SOUTH AFRICA MARKET OVERVIEW
11.6.1. South Africa Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.6.2. South Africa Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By End user (US$ Mn)
11.7. SAUDI ARABIA MARKET OVERVIEW
11.7.1. Saudi Arabia Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.7.2. Saudi Arabia Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By End user (US$ Mn)
11.8. UAE MARKET OVERVIEW
11.8.1. UAE Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.2. UAE Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By End user (US$ Mn)
12. SOUTH AND CENTRAL AMERICA INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA INHALABLE DRUG DELIVERY DEVICES MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.4. SOUTH AND CENTRAL AMERICA INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.5. SOUTH AND CENTRAL AMERICA INHALABLE DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.6. BRAZIL MARKET OVERVIEW
12.6.1. Brazil Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.6.2. Brazil Inhalable Drug Delivery Devices Market Revenue Forecasts and Analysis - By End user (US$ Mn)
13. INHALABLE DRUG DELIVERY DEVICES MARKET, KEY COMPANY PROFILES
13.1. BESPAK
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. PROPELLER HEALTH
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. OMRON CORPORATION
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GLAXOSMITHKLINE PLC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. SWOT Analysis
13.5.6. Key Developments
?
13.6. ASTRAZENECA
13.6.1. Business Description
13.6.2. Financial Overview
13.6.3. Product Portfolio
13.6.4. SWOT Analysis
13.6.5. Key Developments
13.7. SUNOVION PHARMACEUTICALS INC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PFIZER INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. F. HOFFMANN-LA ROCHE LTD
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MONAGHAN MEDICAL CORPORATION
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
14.3. RESEARCH METHODOLOGY
The List of Companies

1. Bespak
2. Propeller Health
3. Boehringer Ingelheim International GmbH
4. Omron Corporation
5. Glaxosmithkline Plc
6. Astrazeneca
7. Sunovion Pharmaceuticals Inc.
8. Pfizer Inc.
9. F. Hoffmann-La Roche Ltd
10. Monaghan Medical Corporation

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book